|1.||Cheng, Liang: 10 articles (11/2015 - 08/2006)|
|2.||Amin, Mahul B: 8 articles (07/2014 - 11/2003)|
|3.||Eble, John N: 7 articles (11/2015 - 08/2006)|
|4.||Michal, Michal: 6 articles (08/2015 - 12/2008)|
|5.||Hes, Ondrej: 6 articles (08/2015 - 12/2008)|
|6.||Gurzu, Simona: 6 articles (07/2015 - 01/2010)|
|7.||Zhang, Shaobo: 5 articles (11/2015 - 04/2008)|
|8.||Grignon, David J: 5 articles (11/2015 - 08/2008)|
|9.||Kuroda, Naoto: 5 articles (08/2015 - 06/2008)|
|10.||Paner, Gladell P: 5 articles (07/2014 - 09/2002)|
01/01/2014 - "Cytokeratin 7 as a predictive factor for response to concommitant radiochemotherapy for locally advanced cervical cancer: a preliminary study."
11/01/2015 - "Staining for cytokeratin 7 (CK7) was focal (64%) or negative (18%) in most tumors (82%); however, >50% labeling was present in 4 (18%). "
08/01/2015 - "All 18 tumors were positive for cytokeratin 7 and CD117. "
12/01/2014 - "However, considering the differential diagnosis, the best discriminator of a secondary tumor is the combination of tumor size, laterality and the pattern of expression of cytokeratin 7 and MUC2."
12/01/2014 - "However, after multivariate analysis, the best predictors of a secondary tumor were a size of 10.0 cm or less, bilaterality and cytokeratin 7 negativity. "
11/01/1993 - "Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary."
01/01/2015 - "Expression of cytokeratin 7 (CK7) is established in most malignancies including gastric and colorectal adenocarcinoma. "
01/01/2015 - "A biopsy of supraclavicular lymph node was performed and the histopathology showed poorly differentiated adenocarcinoma with cytokeratin-7 (CK-7) and thyroid transcription factor-1 (TTF-1) being positive immunohistochemically. "
11/01/2013 - "CCCL tended to be present in older individuals with an adenocarcinoma immunophenotype (cytokeratin 7 and TTF1 positivity). "
01/01/2012 - "The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody."
03/01/2006 - "The combination of immunohistochemistry for cytokeratin 7 and 20 appeared to be a useful tool in determining the site of origin and helpful for premortem diagnosis of the origin of unknown primary carcinoma."
06/01/2015 - "Cytokeratin 7 negative invasive breast carcinoma: clinicopathological and immunohistochemical analysis of 14 cases with clinical follow-up."
10/01/2011 - "Additionally, unlike primary carcinomas, the majority (82%) of metastatic NETs were negative for cytokeratin 7, and all were negative for gross cystic disease fluid protein 15 and mammoglobin. "
03/01/2011 - "In four cases, determination of the primary site finally became possible by comparison with the histological findings of operative specimens in past carcinoma and/or in consideration of radiological findings and the results of cytokeratin 7/20 phenotyping. "
01/01/2011 - "Cytokeratin 7 and 20 expression in gallbladder carcinoma."
|4.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/01/2012 - "Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma."
09/01/2010 - "To evaluate cytokeratin 7 (CK7) immunoreactivity in invasive primary cutaneous squamous cell carcinomas (SCCs). "
11/01/2008 - "Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus."
01/01/1993 - "Our study demonstrates that this keratin 7 antibody is useful in differentiating between squamous cell carcinoma and adenocarcinoma of the lung and it may be particularly useful in making the correct diagnosis in small lung biopsy specimens."
07/01/2013 - "Cytokeratin 7 (CK7) and Cam 5.2 are often used to differentiate extramammary Paget's disease (EPD) from squamous cell carcinoma (SCC) in situ because they are generally considered to be expressed in the former but not in the latter. "
|5.||Sarcoma (Soft Tissue Sarcoma)
04/01/2003 - "Cytokeratin 7 and 20 expression in epithelioid sarcoma."
08/01/2009 - "Lung biopsy revealed poorly differentiated adenocarcinoma positive for cytokeratin 7. Renal, sarcoma, and gastrointestinal markers were negative. "
08/01/2010 - "Sarcolectin (SCL) is a 55 kDa protein cross-reacting with a cytokeratin 7 monomer found in placental blood, sarcomas and various tissues. "
07/01/2003 - "Immunohistochemical study of the excised primitive spindle cell sarcoma revealed occasional positive stains by hitherto reported antigens of S-100, cytokeratin 7, high molecular weight cytokeratin (34 beta E12), pankeratin (AE1/AE3), and EMA, which were helpful for the differential diagnosis of other spindle cell sarcomas. "
01/01/2014 - "Expression of markers specific for glandular (TTF-1, napsin A, cytokeratin 7), squamous cell (p40, p63, cytokeratins 5/6, desmocollin-3), and neuroendocrine (chromogranin, synaptophysin, CD56) differentiation was studied in 121 LCC across their entire histological spectrum also using direct sequencing for epidermal growth factor receptor (EGFR) and v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations and FISH analysis for ALK gene translocation. "
|1.||Keratin-20 (Cytokeratin 20)
|5.||Keratin-5 (Keratin 5)
|8.||Mucin-1 (CA 15-3 Antigen)
|1.||Lymph Node Excision (Lymph Node Dissection)
|5.||Mohs Surgery (Mohs' Micrographic Surgery)